Published in Vaccine on October 10, 2005
Entolimod, an Adjuvant for Vaccine Augmentation | NCT03063736
Quantitative analysis of levels of serum immunoglobulin G against botulinum neurotoxin type D and association with protection in natural outbreaks of cattle botulism. Clin Vaccine Immunol (2006) 0.80
Randomized clinical trial to evaluate the immunogenicity of quadrivalent meningococcal conjugate and polysaccharide vaccines in adults in the United kingdom. Clin Vaccine Immunol (2014) 0.78
A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine. Vaccine (2009) 1.80
Should patients who use illicit drugs be offered a second heart-valve replacement? Tidsskr Nor Laegeforen (2013) 1.46
[Risk of infection through use of selective immunomodulating drugs for rheumatoid arthritis]. Tidsskr Nor Laegeforen (2012) 1.39
An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. Vaccine (2010) 1.32
Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial. Vaccine (2011) 1.18
T-helper 1 cells elicited by H5N1 vaccination predict seroprotection. J Infect Dis (2012) 1.14
Tickborne encephalitis virus, Norway and Denmark. Emerg Infect Dis (2006) 0.98
Molecular characterization of Corynebacterium diphtheriae isolates, Russia, 1957-1987. Emerg Infect Dis (2002) 0.87
The protein kinase C agonist PEP005 increases NF-kappaB expression, induces differentiation and increases constitutive chemokine release by primary acute myeloid leukaemia cells. Br J Haematol (2009) 0.82
Incidence, clinical characteristics and outcome in Norwegian children with periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome; a population-based study. Acta Paediatr (2012) 0.82
Matrix M(TM) adjuvanted virosomal H5N1 vaccine induces balanced Th1/Th2 CD4(+) T cell responses in man. Hum Vaccin Immunother (2014) 0.82
Short-term booster effect of diphtheria toxoid in initially long-term protected individuals. Vaccine (2005) 0.81
[Aminoglycosides should still be used in empirical sepsis treatment]. Tidsskr Nor Laegeforen (2013) 0.77
[Hepatitis C in Northern Norway--an 8-year material]. Tidsskr Nor Laegeforen (2002) 0.76
Antidiphtheria antibody responses in patients and carriers of Corynebacterium diphtheriae in the Arkhangelsk region of Russia. Clin Vaccine Immunol (2006) 0.76
[Use of a new antibiotic in Norway]. Tidsskr Nor Laegeforen (2007) 0.75
[Periodic fever syndrome in children]. Tidsskr Nor Laegeforen (2007) 0.75
[A man with pain following a knee operation]. Tidsskr Nor Laegeforen (2012) 0.75
Co-occurrence of Epstein-Barr virus infection and ascites in sarcoidosis. Scand J Infect Dis (2004) 0.75
Seroprotection against diphtheria and tetanus among Russian and Norwegian teenagers. APMIS (2006) 0.75